The potential merger of pharmaceutical companies AstraZeneca and Pfizer will be considered by the Science and Technology Committee in a one-off session to be held on 14 May.
The Committee will take evidence from both companies and from David Willetts MP, the Minister for Universities and Science, on the potential impact on the 30,000 British jobs supported by AstraZeneca.
Andrew Miller MP, who chairs the committee, said the hearing "will be an opportunity for us to scrutinise the pledges on research and development being made as part of this potential takeover, and pose questions about how the Government will ensure that these commitments are met.”
Pfizer has until Monday until it admits defeat in bidding for AstraZeneca. But after the shenanigans of the past few days we cannot be sure.
AstraZeneca's share price is tumbling back down to earth after the board rejected a "final" Pfizer bid. So is the takeover really over?
Sweden's Finance Minister says the Government should be "very, very sceptical" about any promises the US pharmaceutical giant makes.